Joseph E. Payne

Chief Executive Officer, Arcturus Therapeutics.

Companies

Arcturus TherapeuticsBoard member Aug 30, 2019 to now¹
Arcturus TherapeuticsChief executive officer Aug 30, 2019 to now¹
Arcturus TherapeuticsPresident Aug 30, 2019 to now¹
GRI Bio, Inc.Board member Feb 10, 2021 to Jun 10, 2022²
Arcturus TherapeuticsChief executive officer Jan 2, 2019 to Feb 11, 2019³
Arcturus TherapeuticsPresident Jan 2, 2019 to Feb 11, 2019³
Arcturus TherapeuticsBoard member Jan 2, 2019 to Jan 2, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arcturus Therapeutics ARCT1,480,097 shares⁴$15.3M at $10.34Nov 23, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 23, 2022Bought 5,000 shares at $16.51 of Arcturus Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArcturus Therapeutics, Board member
2
SEC EDGARGRI Bio, Inc., Board member
3
SEC EDGARArcturus Therapeutics, Chief executive officer
4
SEC EDGARArcturus Therapeutics shares after the filing of Nov 23, 2022